Blog: Nestle turns to Chinese medicine
Dean Best | 29 November 2012
In another sign the world's largest food maker is not just about Kit Kats, Nescafe or Maggi noodles, the Swiss food giant is now looking to use Chinese medicine in its fledgling health science business.
Nestle and pharma and healthcare group Chi-Med are going to team up and look into developing "nutritional and medicinal products" using botanical plants.
"This joint venture provides Nestlé Health Science with an opportunity to develop and commercialise truly innovative and scientifically validated botanical-based nutrition for personalised healthcare in gastrointestinal health," Luis Cantarell, president and CEO for Nestlé Health Science, said.
Hutchison MediPharma Limited, a subsidiary of Chi-Med, is already developing what Nestle called a "first-of-its-kind botanical product", to be taken orally, to manage moderate inflammatory bowel disease.
The venture may raise some eyebrows in the food industry but it is a sign Nestle is confident efforts to carve a third way between nutrition and pharmaceuticals will pay dividends in a world facing growing health challenges from non-communicable diseases and, in the developed world, ageing populations.
just-food is closed on Monday (29 August) for a public holiday but, while we down tools, catch up on some must-read insight and interviews....
General Mills is reportedly preparing long-time executive Jeff Harmening to succeed Ken Powell as CEO....
After starting the week with a surprise stock exchange announcement that hit its shares and called into questions its accounting practices, Hain Celestial could be set to receive a boost in the UK....
- Why Jet.com purchase could boost Wal-Mart online
- Nestle on China, candy, nutrition - analysis
- Interview, part 1: Emmi CEO Urs Riedener
- Murray Goulburn's FY results - 7 things to learn
- England child obesity plan should cheer industry
- Mondelez buys rest of Vietnam snacks business
- Australia launches dairy sector probe
- Tyson faces investor scrutiny on ethical issues
- Mengniu grows sales but net profit slips
- Nomad Foods touts progress as H1 results worsen